Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.

Saved in:
Bibliographic Details
Title: Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.
Authors: Green JL; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA. jgreen@inflexxion.com., Dailey-Govoni T; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA., Vosburg SK; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA.
Source: Pain and therapy [Pain Ther] 2026 Jun; Vol. 15 (3), pp. 751-763. Date of Electronic Publication: 2026 Apr 15.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634491 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8237 (Print) NLM ISO Abbreviation: Pain Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41984416
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Green+JL%22">Green JL</searchLink>; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA. jgreen@inflexxion.com.<br /><searchLink fieldCode="AU" term="%22Dailey-Govoni+T%22">Dailey-Govoni T</searchLink>; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA.<br /><searchLink fieldCode="AU" term="%22Vosburg+SK%22">Vosburg SK</searchLink>; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634491%22">Pain and therapy</searchLink> [Pain Ther] 2026 Jun; Vol. 15 (3), pp. 751-763. <i>Date of Electronic Publication: </i>2026 Apr 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634491 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8237 (Print) <i>NLM ISO Abbreviation: </i>Pain Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41984416
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40122-026-00835-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 751
    Titles:
      – TitleFull: Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Green JL
      – PersonEntity:
          Name:
            NameFull: Dailey-Govoni T
      – PersonEntity:
          Name:
            NameFull: Vosburg SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8237
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pain and therapy
              Type: main
ResultId 1